Remove www.debiopharm.com
article thumbnail

Investment fuels AI-driven development of breakthrough genomic medicines

pharmaphorum

He explains that bringing cutting-edge genomic therapies to market which could treat or cure life-threatening diseases can take up to 15 years and cost $2 billion – far too slow to match patients’ needs, and far too expensive on the healthcare system. “We It can be life-changing for patients.”. It can be life-changing for patients.”.

article thumbnail

How a new investment is powering a revolution in clinical trial operations

pharmaphorum

Trial sites monitor patients participating in a research programme and enter their data into an electronic health record (EHR) for storage before transferring it to the trial’s electronic data capture (EDC) system. Only 5% of cancer patients have access to clinical trials. Today, Peleg explains, much of this process remains manual.